Find out about the ESC Working Groups sessions of interest at ESC Congress 2023
Working Group on Adult Congenital Heart Disease
Top tips in managing heart failure in adult congenital heart disease
Acute heart failure in adult congenital heart disease - Joint session with the Association for European Paediatric and Congenital Cardiology (AEPC)
Myocardial performance in adult congenital heart disease
Meet the Experts: peripheral artery disease from diagnosis to interventions
Proximal thoracic aortopathy: what is known, what is not, what is new
Working Group on Atherosclerosis and Vascular Biology
Cellular communications at single-cell resolution in cardiovascular diseases
Heart brain interactions in cardiovascular diseases
Novel targets for treatment of atherosclerosis
ESC William Harvey Lecture in Basic Science
Working Group on Cardiac Cellular Electrophysiology
The role of ageing in cardiac arrhythmias
Working Group on Cardiovascular Pharmacotherapy
Global burden of cardiovascular disease and risks: what should European cardiovascular clinicians do? - Joint session with the Journal of the American College of Cardiology (JACC)
Better clinical trials in cardiology
Meet the Experts: cardiovascular care in complex elderly patients - Organised in collaboration with the ESC Council for Cardiology Practice and the Netherlands Society of Cardiology
Modifying lipids to decrease cardiovascular risk
Great Debate: should we still target triglycerides to decrease cardiovascular risk?
Working Group on on Cardiovascular Regenerative and Reparative Medicine
Cellular communications at single-cell resolution in cardiovascular diseases
Novel mechanistic insights into arrhythmias
RNA therapeutics for cardiovascular disease
Pathophysiology of heart failure: basic mechanisms
Circulation: the full spectrum - Joint session with Circulation
Working Group on Cardiovascular Surgery
Proximal thoracic aortopathy: what is known, what is not, what is new
2023 ESC Guidelines for the management of Endocarditis
2023 ESC Guidelines for the management of Acute Coronary Syndromes
Managing cardiogenic shock: the keys to success
Secondary mitral regurgitation in heart failure: what´s new?
Working Group on Cellular Biology of the Heart
Novel targets for treatment of atherosclerosis
Cellular communications at single-cell resolution in cardiovascular diseases
Young Investigator Awards Session in Coronary Pathophysiology and Microcirculation
HFpEF: mechanisms and translational perspectives
ESC William Harvey Lecture in Basic Science
Women, dyslipidaemia and atherosclerosis: what is different?
Heart and brain interactions - Joint session with the European Academy of Neurology (EAN)
Working Group on Development Anatomy and Pathology
Young Investigator Awards Session in Basic Science
Working Group on e-Cardiology
Great Debate: will artificial intelligence replace cardiologists?!
Why is everybody talking about AI chatbots like ChatGPT?
The latest in cardiovascular diagnostics supported by artificial intelligence
Great Debate: can we trust artificial intelligence in cardiac imaging today?
Working Group on Myocardial & Pericardial Diseases
2023 ESC Guidelines for the Management of Cardiomyopathies
New perspectives in hypertrophic cardiomyopathy - Joint session with the Mexican Society of Cardiology (MSC)
Genetic cardiomyopathies and channelopathies: close to personalised treatment strategies?
Is an athlete with implantable cardioverter defibrillator eligible for competitive sports?
Working Group on Myocardial Function
RNA therapeutics for cardiovascular disease
HFpEF: mechanisms and translational perspectives
Metabolism and cardiovascular diseases: completely inseparable
Translational insights from cardioimmunology for human heart failure
Working Group on Pulmonary Circulation & Right Ventricular Function
Early diagnosis of pulmonary arterial hypertension: is it possible?
Pulmonary hypertension in patients with cardiopulmonary comorbidities: the challenges - Joint session with the European Respiratory Society (ERS)
Molecular approaches to the treatment of pulmonary hypertension
Guidelines in Practice: evolving management of intermediate high-risk acute pulmonary embolism
Our mission: To reduce the burden of cardiovascular disease.